Home › Bronchiolitis Obliterans › Massachusetts › Boston
Bronchiolitis Obliterans clinical trials in Boston, MA
4 studies for Bronchiolitis Obliterans are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Plasma and Radiologic Biomarkers of Response to ECP in Lung Transplant Recipients With CLAD
RecruitingObservational study
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
RecruitingObservational study
- Dana-Farber Cancer Institute/Boston Children's Hospital, Boston
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
RecruitingPhase 2
- Dana-Farber Cancer Institute, Boston
Other studies in Boston
- Breast Cancer111 studies
- Non-Small Cell Lung Cancer90 studies
- Cancer (all types)86 studies
- Colorectal Cancer63 studies
- Metastatic Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer59 studies
- Depression52 studies
- Endometrial Cancer50 studies
- Heart Failure44 studies
- Acute Myeloid Leukemia44 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.